Received: 15 October 2022
Accepted: 15 March 2023
First Online: 25 March 2023
: The present study was approved by the Ethics Committee of Weifang People’s Hospita(2021037), and was registered in the Chinese Clinical Trial Registry.( ChiCTR2100053444). Informed consent was obtained from all subjects or their legal guardian. The study protocol followed the CONSORT guidelines. The study protocol was performed in the relevant guidelines.
: Not applicable.
: The authors declare that they have no conficts of interest.